Amicus Therapeutics vs Harmony Biosciences Holdings
Amicus Therapeutics vs Harmony Biosciences Holdings, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amicus Therapeutics is on 57/100 and Harmony Biosciences Holdings on 57/100.
Where each one leads
Amicus Therapeutics
- domain rating: 66/100 against 55/100
- headcount: 625 against 332
- LinkedIn following: 57,431 against 22,304
Harmony Biosciences Holdings
- agent readiness: 39/100 against 21/100
- funding raised: $401M against $200M
At a glance
| Measure | Amicus Therapeutics | Harmony Biosciences Holdings |
|---|---|---|
| What it is | Biotechnology company focused on developing treatments for rare metabolic diseases. | Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Services |
| Founded | 2002 | 2017 |
| Headquarters | Philadelphia, United States | Plymouth Meeting, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Amicus Therapeutics | Harmony Biosciences Holdings |
|---|---|---|
| Employees | 625 | 332 |
| Total funding | $200M | $401M |
| Latest round | Series D | IPO |
| LinkedIn followers | 57,431 | 22,304 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Amicus Therapeutics | Harmony Biosciences Holdings |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 57/100 |
| Traction | 60/100 | 60/100 |
| Team | 30/100 | 30/100 |
| Search visibility | 34/100 | 33/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 66/100 | 55/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Amicus Therapeutics | Harmony Biosciences Holdings |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Analytics | Not detected | Google Tag Manager |
Amicus Therapeutics vs Harmony Biosciences Holdings: common questions
Which is better, Amicus Therapeutics or Harmony Biosciences Holdings?
Both score the same on our 0-100 rating, so the choice comes down to the 18 data points in the tables above rather than overall company strength.
How do Amicus Therapeutics and Harmony Biosciences Holdings compare on the numbers?
Amicus Therapeutics leads on domain rating (66/100 against 55/100), headcount (625 against 332), LinkedIn following (57,431 against 22,304). Harmony Biosciences Holdings leads on agent readiness (39/100 against 21/100), funding raised ($401M against $200M).
Read the full Amicus Therapeutics review and pricing or the Harmony Biosciences Holdings review and pricing. You can also browse other Amicus Therapeutics alternatives we track.